Browse By Keyword Advanced Molecular Detection
ASM is launching multi-stakeholder effort to help advance genetic sequencing and tracking of COVID-19 variants and inform make clinical and public health decisions.
ASM hails the inclusion of $1.75 billion for CDC’s Advanced Molecular Detection (AMD) program in the American Rescue Plan Act signed into law by President Biden.
ASM strongly supports provisions to bolster genomic surveillance and sequencing of SARS-CoV-2 included in H.R. 1319, the American Rescue Plan Act.